Navigation Links
Are research participants safe enough?
Date:4/26/2010

Every year, millions of patients worldwide participate in randomized clinical trials hoping to benefit from an experimental treatment or potentially help someone else with the same condition.

However, rules and regulations are becoming a menace to academic clinical trials where resources are limited and risks may be much less than those associated with new experimental drugs.

"There is no question that research participants need protection," write Paul Hbert, Editor-in-Chief, CMAJ, and coauthors. "But regulations have grown so burdensome that they are overwhelming the very things they are meant to support and safeguard. Consequently, clinical research has been substantially decreased among industrialized countries."

International bodies, regulatory authorities, the academic community and major granting agencies need to work together to develop and adopt proper, study-specific standards instead of having ineffective monitoring of all clinical research.

The authors conclude that without significant changes, our academic research enterprise and eventually even commercial trials will be immobilized by increasing bureaucracy and spiraling costs.


'/>"/>

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116 x2224
Canadian Medical Association Journal
Source:Eurekalert

Page: 1

Related medicine news :

1. Scientific meeting will host new research in childrens ear, nose and throat health
2. Los Angeles Plastic Surgeon is the New President of the Aesthetic Surgery and Research Foundation (ASERF)
3. Cancer research award to Johns Hopkins basic scientist
4. Parkinson's Disease Patient's Story Goes Multimedia, Proceeds to Benefit PD Research
5. Nutrition researchers to develop new growth charts for children with Down syndrome
6. MU researchers show potential for new cancer detection and therapy method
7. Provalis Research Announces the Release of WordStat 6, Delivering Enhanced Analytical and Visualization Tools for Textual Data
8. Researchers successfully lower radiation dose associated with pediatric chest CT scans
9. Researchers identify a new breast and ovarian cancer susceptibility gene
10. Researchers show that nitric oxide-donating naproxen can boost colorectal cancer prevention
11. Lombardi research teams hone in on treatments for osteosarcoma and Ewings sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... In 2014, Harvard researchers published ... approximately 800 deaths from prostate cancer, the researchers found that men who had undergone ... to get fatal prostate cancer. Although the increased risks are small, they seem to ...
(Date:2/28/2017)... Pekin, IL (PRWEB) , ... February 28, 2017 ... ... over the past decade, has challenges as they transition from military to civilian ... population of over two million who experience poorer health and greater occurrence of ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... Robert E. ... large medical group. But his impoverished upbringing and life experiences could have led him ... a Physician: Insightful and Inspirational Tales of Parenting, Perseverance and Pediatrics,” Dr. Burke shares ...
(Date:2/27/2017)... ... February 27, 2017 , ... Orange County dentist, Dr. A. Rassouli, ... that occurs when the bacteria in plaque infect the gums and other tissues supporting ... and root planing or SRP, and can include surgical therapies if the condition has ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine ... programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce ... hire, Mackenzie Alsager, showcases the Centre's commitment to innovation in drug rehab and ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... ... has announced the addition of the "Ovarian Cancer Drugs Price Analysis ... The latest research Ovarian Cancer Drugs Price Analysis and Strategies - 2016, ... The research answers the following questions: ... clinical attributes? How are they positioned in the Global Ovarian Cancer market? ...
(Date:2/28/2017)... , Feb. 28, 2017  Rigel Pharmaceuticals, Inc. (Nasdaq: ... will report its fourth quarter and year end ... 7, 2017.  Rigel senior management will follow the ... at 5:00pm Eastern Time (2:00pm Pacific Time) to ... access the live conference call by dialing 855-892-1489 ...
(Date:2/28/2017)... FRANCISCO , February 27, 2017 ... D BioMedical assets for ... LOI contemplates capital infusion into Amarantus ...   Amarantus names four new appointees to its Board of ... SeD Biomedical Inc. (SeD Biomedical) , a ...
Breaking Medicine Technology: